Cold activation of complement enhancing with the duration of storage in sera from blood donors with hepatitis C virus RNA
スポンサーリンク
概要
著者
-
OKAMOTO Hiroaki
Immunology Division and Division of Molecular Virology, Jichi Medical School
-
MIYAKAWA Yuzo
Miyakawa Memorial Research Foundation
-
Tsuda Fumio
Department Of Medical Sciences Toshiba General Hospital
-
Mayumi Makoto
Immunology Division Jichi Medical School
-
Mayumi Makoto
Immunology Division And Division Of Molecular Virology Jichi Medical School
-
Okamoto Hiroaki
Immunology Division And Division Of Molecular Virology Jichi Medical School
-
Okamoto Hiroaki
Immunology Division Jichi Medical School
-
Hirakawa Kazuya
Japanese Red Cross Yamaguchi Blood Center
-
Itoh Keiichi
Japanese Red Cross Yamaguchi Blood Center
-
TANAKA Hidenori
Japanese Red Cross Yamaguchi Blood Center
-
SHIGA Jun-ichi
Japanese Red Cross Yamaguchi Blood Center
-
OKAMOTO Hiroaki
Immunology Division, Jichi Medical School
関連論文
- TT virus infection in cases of fulminant hepatic failure-evaluation by clonality based on amino acid sequence of hypervariable regions
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
- Circulating KL-6 level at baseline is a predictive indicator for the occurrence of interstitial pneumonia during interferon treatment for chronic hepatitis C
- TT virus of certain genotypes may reduce the platelet count in patients who achieve a sustained virologic response to interferon treatment for chronic hepatitis C
- Influence of TT virus infection on the thrombocytopenia of patients with chronic liver disease
- Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease
- Influence of TT virus on the clinical course of alcoholic liver disease
- Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy
- Little contribution of GB virus C to the development of primary hepatocellular carcinoma in Japan
- TT virus : virological and genomic characteristics and disease associations
- Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment : Study on 1019 carriers followed for 5-10 years
- Helicobacter pylori and TT virus prevalence in Japanese children
- Clinical evaluation of chronic liver diseases induced by different hepatitis C virus genotype in Japan, focused on the difference between genotypes III/2a and IV/2b
- Hepatic histopathologic range compared with virological studies of hepatitis viruses among autopsy cases in Tokyo
- Immunoadjuvant activity of crude lectin extracted from Momordica charantia seed
- Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology^1
- Differential effect of cytotoxic T lymphocyte variant epitopes on generation and cytotoxicity in chronic hepatitis C virus infection
- The prevalence of GB virus C, risk factors and its relationship with other hepatitis viruses in a general population in Jakarta, Indonesia
- Cold activation of complement enhancing with the duration of storage in sera from blood donors with hepatitis C virus RNA
- HLA B44-restricted cytotoxic T lymphocyte responses to the peptides of HCV nucleprotein residues 81-100 in patients with chronic hepatitis C
- IgM-class antibodies to TT virus (TTV) in patients with acute TTV infection
- A unique set of mutations in the 'preX' region of hepatitis B virus DNA frequently foun in patients but not in asymptomatic carriers: implication for a novel variant
- Hepatitis C virus genotypes and co-infection with GB virus C in patients with anti-HCV-positive chronic liver disease in Jakarta, Indonesia
- Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
- Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks
- Genotypes of GB virus C and hepatitis C virus in hepatitis patients in India, Iran and Slovenia
- Efficacy of hepatitis B vaccines with and without preS2-region product in Sumo wrestlers in Japan
- Molecular and clinical characteristics of the hepatitis C virus genotype '2c' found in Italians in Italy and France
- Infection with GB virus C in the patients with primary hepatocellular carcinoma in Japan
- Immunoprophylaxis of perinatal infection with hepatitis B virus on the national scale
- Prevalence of Anti-Hepatitis C antibodies in a Rural Community without High Mortality from Liver Disease in Niigata Prefecture
- Persistence of hepatitis B viremia after recovery from acute hepatitis B : correlation between anti-HBc titer and HBV DNA in serum
- Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
- Rebound of hepatitis C virus RNA in serum after withdrawal of interferon in patients with advanced liver disease
- Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
- Follow up of the 987 blood donors found with hepatitis C virus infection over 9-18 years